Exercise of Share Options

RNS Number : 9998H
Science Group PLC
30 November 2022
 

 

30 November 2022

 

Science Group plc

(the "Company" or "Science Group")

 

Exercise of Share Options

 

Science Group plc (AIM:SAG) announces that on 29 November 2022 the Company issued 69,600 shares from the Frontier Smart Technologies Employee Benefit Trust at an average price of 1 pence per share in settlement of the exercise of share options. 

 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 45,436,823.  Science Group holds 749,051 shares in treasury and a further 34,800 shares are held by the Frontier Smart Technologies Employee Benefit Trust.  The total number of voting rights in the Company following this announcement is therefore 45,402,023.

 

The figure of 45,402,023 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

 

- Ends -

 

 

For further information:

Science Group plc


Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com  

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)


Nick Adams, Alex Price, Richard Short

Tel: +44 (0) 20 7710 7600



Liberum Capital Limited (Joint Broker)


Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKCBQKBDBQDB
UK 100

Latest directors dealings